Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +36.36%
#2 Versatize Coin Versatize Coin +32.50%
#3 Purr Purr +30.40%
#4 Siren Siren +30.34%
#5 ApeX ApeX +16.64%
#6 UnifAI Network UnifAI Network +15.84%
#7 OriginTrail OriginTrail +15.24%
#8 Pendle Pendle +14.37%
#9 龙虾 (Lobster) 龙虾 (Lobster) +13.15%
#10 DigiByte DigiByte +13.10%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Bharat Parenterals Limited Bharat Parenterals Limited

Bharat Parenterals Limited

BPLPHARMA
Rank in Stocks #21540
Bharat Parenterals Limited specializes in the development and production of... Bharat Parenterals Limited specializes in the development and production of pharmaceutical formulations, offering a broad spectrum of products. Their diverse portfolio encompasses general-purpose medicines, B-Lactam compounds, cephalosporin-based drugs, anti-retroviral therapies, and veterinary pharmaceuticals. This company was established by Ramesh Desai on September 3, 1992, and operates from its main office situated in Vadodara, India.
Share Price
$15.26
Last synced: 2026-08-21
Market Cap
$105.18M
Change (1 day)
3.28%
Change (1 year)
-4.12%
Country
IN
Trade Bharat Parenterals Limited (BPLPHARMA)

Category

Healthcare
Revenue for Bharat Parenterals Limited (BPLPHARMA)
Revenue in Aug 2026 TTM: 0
According to Bharat Parenterals Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bharat Parenterals Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT